Phase 3 Trial for Promising Melanoma Vaccine | www.bioquicknews.com

Posted by Admin on Apr 6th, 2010 in Cancer, Melanoma, Skin Cancer, chicago | 0 comments

Rush University Medical Center in Chicago is leading a nationwide phase 3 clinical trial to determine whether a promising vaccine for advanced melanoma can effectively treat the deadly skin cancer. An earlier phase 2 trial of the …

View original post here:
Phase 3 Trial for Promising Melanoma Vaccine | www.bioquicknews.com

Tags

and-the asbestos asbestos-exposure- body breast colon-and diagnosed-with disease first for-the from-the has-been have-been health Leukemia lining lung lungs medical medicine Melanoma Mesothelioma mesothelium most most-common new-study research risk skin society symptoms the- the-body- the-disease- the-lungs- the-most there-are treatment type united united-states university with-the world you-have

WP Cumulus Flash tag cloud by Roy Tanck and Luke Morton requires Flash Player 9 or better.

Phase 3 Trial for Promising Melanoma Vaccine | www.bioquicknews.com

Leave a Reply

Tags